Old and new selective pressures on Mycobacterium tuberculosis

Infection, Genetics and Evolution

Volumn 12, Issue 4, 2012, Pages 678-685

  Brites, Daniela ^a,b   Gagneux, Sebastien ^a,b  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Co infection; Drug resistance; HIV; Immunity; Selection; Tuberculosis

Indexed keywords

MOLECULAR MARKER; TUBERCULOSTATIC AGENT;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; DEMOGRAPHY; DISEASE TRANSMISSION; DRUG RESISTANCE; HOST PATHOGEN INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFECTION RISK; LONG TERM EXPOSURE; MIXED INFECTION; MOLECULAR EVOLUTION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POPULATION RESEARCH; PRIORITY JOURNAL; SPUTUM SMEAR; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; COINFECTION; DRUG RESISTANCE, BACTERIAL; EVOLUTION, MOLECULAR; GENETIC VARIATION; HIV INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; MYCOBACTERIUM TUBERCULOSIS; SELECTION, GENETIC; TUBERCULOSIS;

MYCOBACTERIUM TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS COMPLEX;

EID: 84858735387     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2011.08.010     Document Type: Article

References (89)

1. Ahmed N., Caviedes L., Alam M., Rao K.R., Sangal V., Sheen P., Gilman R.H., Hasnain S.E. Distinctiveness of Mycobacterium tuberculosis genotypes from human immunodeficiency virus type 1-seropositive and -seronegative patients in Lima, Peru. J. Clin. Microbiol. 2003, 41:1712-1716.
2. Anderson R.M., May R.M. Coevolution of hosts and parasites. Parasitology 1982, 85(Pt 2):411-426.
3. Andersson D.I., Hughes D. Antibiotic resistance and its cost: is it possible to reverse resistance?. Na. Rev. Microbiol. 2010, 8:260-271.
4. Asiimwe B.B., Joloba M.L., Ghebremichael S., Koivula T., Kateete D.P., Katabazi F.A., Pennhag A., Petersson R., Kallenius G. DNA restriction fragment length polymorphism analysis of Mycobacterium tuberculosis isolates from HIV-seropositive and HIV-seronegative patients in Kampala, Uganda. BMC Infect Dis. 2009, 9:12.
5. Baker L., Brown T., Maiden M.C., Drobniewski F. Silent nucleotide polymorphisms and a phylogeny for Mycobacterium tuberculosis. Emerg. Infect. Dis. 2004, 10:1568-1577.
6. Barnes I., Duda A., Pybus O.G., Thomas M.G. Ancient urbanization predicts genetic resistance to tuberculosis. Evolution 2011, 65:842-848.
7. Basu S., Galvani A.P. The evolution of tuberculosis virulence. Bulletin of Mathematical Biology 2009, 1:1073-1088.
8. Basu S., Orenstein E., Galvani A.P. The theoretical influence of immunity between strain groups on the progression of drug-resistant tuberculosis epidemics. J. Infect. Dis. 2008, 198:1502-1513.
9. Billington O.J., McHugh T.D., Gillespie S.H. Physiological cost of rifampin resistance induced in vitro in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 1999, 43:1866-1869.
10. Blaser M.J., Kirschner D. The equilibria that allow bacterial persistence in human hosts. Nature 2007, 449:843-849.
11. Borrell S., Gagneux S. Infectiousness, reproductive fitness and evolution of drug-resistant Mycobacterium tuberculosis. Int. J. Tuberc. Lung Dis. 2009, 13:1456-1466.
12. Borrell S., Gagneux S. Strain diversity, epistasis and the evolution of drug resistance in Mycobacterium tuberculosis. Clin. Microbiol. Infect. 2011, 17:815-820.
13. Bottger E.C., Springer B., Pletschette M., Sander P. Fitness of antibiotic-resistant microorganisms and compensatory mutations. Nat. Med. 1998, 4:1343-1344.
14. Brindle R.J., Nunn P.P., Githui W., Allen B.W., Gathua S., Waiyaki P. Quantitative bacillary response to treatment in HIV-associated pulmonary tuberculosis. Am. Rev. Respir. Dis. 1993, 147:958-961.
15. Brosch R., Gordon S.V., Marmiesse M., Brodin P., Buchrieser C., Eiglmeier K., Garnier T., Gutierrez C., Hewinson G., Kremer K., Parsons L.M., Pym A.S., Samper S., van Soolingen D., Cole S.T. A new evolutionary scenario for the Mycobacterium tuberculosis complex. Proc. Natl. Acad. Sci. USA 2002, 99:3684-3689.
16. Brudey K., Driscoll J.R., Rigouts L., Prodinger W.M., Gori A., Al-Hajoj S.A., Allix C., Aristimuno L., Arora J., Baumanis V., Binder L., Cafrune P., Cataldi A., Cheong S., Diel R., Ellermeier C., Evans J.T., Fauville-Dufaux M., Ferdinand S., Garcia de Viedma D., Garzelli C., Gazzola L., Gomes H.M., Gutierrez M.C., Hawkey P.M., van Helden P.D., Kadival G.V., Kreiswirth B.N., Kremer K., Kubin M., Kulkarni S.P., Liens B., Lillebaek T., Ly H.M., Martin C., Mokrousov I., Narvskaia O., Ngeow Y.F., Naumann L., Niemann S., Parwati I., Rahim M.Z., Rasolofo-Razanamparany V., Rasolonavalona T., Rossetti M.L., Rusch-Gerdes S., Sajduda A., Samper S., Shemyakin I., Singh U.B., Somoskovi A., Skuce R., van Soolingen D., Streicher E.M., Suffys P.N., Tortoli E., Tracevska T., Vincent V., Victor T.C., Warren R., Yap S.F., Zaman K., Portaels F., Rastogi N., Sola C. Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology. BMC Microbiol. 2006, 6:23.
17. Bull J.J. Perspective: virulence. Evolution 1994, 48:1423-1437.
18. Carvalho A.C., DeRiemer K., Nunes Z.B., Martins M., Comelli M., Marinoni A., Kritski A.L. Transmission of Mycobacterium tuberculosis to contacts of HIV-infected tuberculosis patients. Am. J. Respir. Crit. Care Med. 2001, 164:2166-2171.
19. Caws M., Thwaites G., Dunstan S., Hawn T.R., Thi Ngoc Lan N., Thuong N.T., Stepniewska K., Huyen M.N., Bang N.D., Huu Loc T., Gagneux S., van Soolingen D., Kremer K., van der Sande M., Small P., Thi Hoang Anh P., Chinh N.T., Thi Quy H., Thi Hong Duyen N., Quang Tho D., Hieu N.T., Torok E., Hien T.T., Dung N.H., Thi Quynh Nhu N., Duy P.M., van Vinh Chau N., Farrar J. The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis. PLoS Pathog. 2008, 4:e1000034.
20. Cohen T., Sommers B., Murray M. The effect of drug resistance on the fitness of Mycobacterium tuberculosis. Lancet Infect. Dis. 2003, 3:13-21.
21. Cohen T., Wilson D., Wallengren K., Samuel E.Y., Murray M. Mixed-strain Mycobacterium tuberculosis infections among patients dying in a hospital in KwaZulu-Natal, South Africa. J. Clin. Microbiol. 2011, 49:385-388.
22. Comas I., Chakravartti J., Small P.M., Galagan J., Niemann S., Kremer K., Ernst J.D., Gagneux S. Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved. Nat. Genet. 2010, 42:498-503.
23. Comas I., Gagneux S. The past and future of tuberculosis research. PLoS Pathog. 2009, 5:e1000600.
24. Comas, I., Gagneux, S., 2011. A case for systems epidemiology in tuberculosis research. Trends Microbiol, in press.
25. Comas I., Homolka S., Niemann S., Gagneux S. Genotyping of genetically monomorphic bacteria: DNA sequencing in Mycobacterium tuberculosis highlights the limitations of current methodologies. PLoS ONE 2009, 4:e7815.
26. Corbett E.L., Charalambous S., Moloi V.M., Fielding K., Grant A.D., Dye C., De Cock K.M., Hayes R.J., Williams B.G., Churchyard G.J. Human immunodeficiency virus and the prevalence of undiagnosed tuberculosis in African gold miners. Am. J. Respir. Crit. Care Med. 2004, 170:673-679.
27. Coscolla M., Gagneux S. Does M. tuberculosis genomic diversity explain disease diversity?. Drug Discov. Today Dis. Mech. 2010, 7:e43-e59.
28. Cowley D., Govender D., February B., Wolfe M., Steyn L., Evans J., Wilkinson R.J., Nicol M.P. Recent and rapid emergence of W-Beijing strains of Mycobacterium tuberculosis in Cape Town, South Africa. Clin. Infect. Dis. 2008, 47:1252-1259.
29. Cruciani M., Malena M., Bosco O., Gatti G., Serpelloni G. The impact of human immunodeficiency virus type 1 on infectiousness of tuberculosis: a meta-analysis. Clin. Infect. Dis. 2001, 33:1922-1930.
30. Daniel T.M. The history of tuberculosis. Respir. Med. 2006, 100:1862-1870.
31. Davis J.M., Ramakrishnan L. The role of the granuloma in expansion and dissemination of early tuberculous infection. Cell 2009, 136:37-49.
32. de Jong B.C., Hill P.C., Aiken A., Awine T., Antonio M., Adetifa I.M., Jackson-Sillah D.J., Fox A., Deriemer K., Gagneux S., Borgdorff M.W., McAdam K.P., Corrah T., Small P.M., Adegbola R.A. Progression to active tuberculosis, but not transmission, varies by Mycobacterium tuberculosis lineage in The Gambia. J. Infect. Dis. 2008, 198:1037-1043.
33. Dye C., Williams B.G. The population dynamics and control of tuberculosis. Science 2010, 328:856-861.
34. Ebert D., Bull J.J. Challenging the trade-off model for the evolution of virulence. is virulence management feasible?. Trends Microbiol. 2003, 11:15-20.
35. Ebert D., Bull J.J. The Evolution and Expression of Virulence. Evolution in Health and Disease 2008, 153-167. Oxford University Press, New York. S.C. Stearns, J.C. Koella (Eds.).
36. Escombe A.R., Moore D.A., Gilman R.H., Pan W., Navincopa M., Ticona E., Martinez C., Caviedes L., Sheen P., Gonzalez A., Noakes C.J., Friedland J.S., Evans C.A. The infectiousness of tuberculosis patients coinfected with HIV. PLoS Med. 2008, 5:e188.
37. Ewald P.W. Host-parasite relations, vectors, and the evolution of disease severity. Annu. Rev. Ecol. Syst. 1983, 14:465-485.
38. Filliol I., Motiwala A.S., Cavatore M., Qi W., Hernando Hazbon M., Bobadilla Del Valle M., Fyfe J., Garcia-Garcia L., Rastogi N., Sola C., Zozio T., Guerrero M.I., Leon C.I., Crabtree J., Angiuoli S., Eisenach K.D., Durmaz R., Joloba M.L., Rendon A., Sifuentes-Osornio J., Ponce de Leon A., Cave M.D., Fleischmann R., Whittam T.S., Alland D. Global phylogeny of Mycobacterium tuberculosis based on Single Nucleotide Polymorphism (SNP) analysis: insights into tuberculosis evolution, phylogenetic accuracy of other DNA fingerprinting systems, and recommendations for a minimal standard SNP Set. J. Bacteriol. 2006, 188:759-772.
39. Flynn J.L., Chan J. Immunology of tuberculosis. Annu. Rev. Immunol. 2001, 19:93-129.
40. Flynn J.L., Chan J. What's good for the host is good for the bug. Trends Microbiol. 2005, 13:98-102.
41. Forte M., Maartens G., Rahelu M., Pasi J., Ellis C., Gaston H., Kumararatne D. Cytolytic T-cell activity against mycobacterial antigens in HIV. AIDS 1992, 6:407-411.
42. Gagneux S., Deriemer K., Van T., Kato-Maeda M., de Jong B.C., Narayanan S., Nicol M., Niemann S., Kremer K., Gutierrez M.C., Hilty M., Hopewell P.C., Small P.M. Variable host-pathogen compatibility in Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 2006, 103:2869-2873.
43. Gagneux S., Long C.D., Small P.M., Van T., Schoolnik G.K., Bohannan B.J. The competitive cost of antibiotic resistance in Mycobacterium tuberculosis. Science 2006, 312:1944-1946.
44. Gagneux S., Small P.M. Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development. Lancet Infect. Dis. 2007, 7:328-337.
45. Gandon S., Agnew P., Michalakis Y. Coevolution between parasite virulence and host life-history traits. Am. Nat. 2002, 160:374-388.
46. Getahun H., Gunneberg C., Granich R., Nunn P. HIV infection-associated tuberculosis: the epidemiology and the response. Clin. Infect. Dis. 2010, 50(3):S201-S207.
47. Godreuil S., Renaud F., Van de Perre P., Carriere C., Torrea G., Banũls A.-L. Genetic diversity and population structure of Mycobacterium tuberculosis in HIV-1-infected compared with uninfected individuals in Burkina Faso. AIDS. 2007, 21:248-250.
48. Gutacker M.M., Mathema B., Soini H., Shashkina E., Kreiswirth B.N., Graviss E.A., Musser J.M. Single-nucleotide polymorphism-based population genetic analysis of Mycobacterium tuberculosis strains from 4 geographic sites. J. Infect. Dis. 2006, 193:121-128.
49. Gutierrez C., Brisse S., Brosch R., Fabre M., Omais B., Marmiesse M., Supply P., Vincent V. Ancient origin and gene mosaicism of the progenitor of Mycobacterium tuberculosis. PLoS Pathogens. 2005, 1:1-7.
50. Handel A., Margolis E., Levin B.R. Exploring the role of the immune response in preventing antibiotic resistance. J. Theor. Biol. 2009, 256:655-662.
51. Helke K.L., Mankowski J.L., Manabe Y.C. Animal models of cavitation in pulmonary tuberculosis. Tuberculosis (Edinb) 2006, 86:337-348.
52. Herb F., Thye T., Niemann S., Browne E.N., Chinbuah M.A., Gyapong J., Osei I., Owusu-Dabo E., Werz O., Rusch-Gerdes S., Horstmann R.D., Meyer C.G. ALOX5 variants associated with susceptibility to human pulmonary tuberculosis. Human molecular genetics 2008, 17:1052-1060.
53. Hershberg R., Lipatov M., Small P.M., Sheffer H., Niemann S., Homolka S., Roach J.C., Kremer K., Petrov D.A., Feldman M.W., Gagneux S. High functional diversity in Mycobacterium tuberculosis driven by genetic drift and human demography. PLoS Biology 2008, 6:e311.
54. Hirsh A.E., Tsolaki A.G., DeRiemer K., Feldman M.W., Small P.M. Stable association between strains of Mycobacterium tuberculosis and their human host populations. Proc. Natl. Acad. Sci. USA 2004, 101:4871-4876.
55. Intemann C.D., Thye T., Niemann S., Browne E.N., Amanua Chinbuah M., Enimil A., Gyapong J., Osei I., Owusu-Dabo E., Helm S., Rusch-Gerdes S., Horstmann R.D., Meyer C.G. Autophagy gene variant IRGM -261T contributes to protection from tuberculosis caused by Mycobacterium tuberculosis but not by M. africanum strains. PLoS Pathog. 2009, 5:e1000577.
56. Kawecki T.J., Ebert D. Conceptual issues in local adaptation. Ecol Lett. 2004, 7:1225-1241.
57. Kwan C.K., Ernst J.D. HIV and tuberculosis: a deadly human syndemic. Clin. Microbiol. Rev. 2011, 24:351-376.
58. Lasunskaia E., Ribeiro S.C., Manicheva O., Gomes L.L., Suffys P.N., Mokrousov I., Ferrazoli L., Andrade M.R., Kritski A., Otten T., Kipnis T.L., da Silva W.D., Vishnevsky B., Oliveira M.M., Gomes H.M., Baptista I.F., Narvskaya O. Emerging multidrug resistant Mycobacterium tuberculosis strains of the Beijing genotype circulating in Russia express a pattern of biological properties associated with enhanced virulence. Microbes Infect. 2010, 12:467-475.
59. Levin B.R. The evolution and maintenance of virulence in microparasites. Emerg. Infect. Dis. 1996, 2:93-102.
60. Levin B.R., Bull J.J. Short-sighted evolution and the virulence of pathogenic microorganisms. Trends Microbiol. 1994, 2:76-81.
61. Lipsitch M., Sousa A.O. Historical intensity of natural selection for resistance to tuberculosis. Genetics 2002, 161:1599-1607.
62. Lloyd-Smith J.O., Schreiber S.J., Kopp P.E., Getz W.M. Superspreading and the effect of individual variation on disease emergence. Nature 2005, 438:355-359.
63. Mariam D.H., Mengistu Y., Hoffner S.E., Andersson D.I. Effect of rpoB mutations conferring rifampin resistance on fitness of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 2004, 48:1289-1294.
64. Middelkoop K., Bekker L.G., Mathema B., Shashkina E., Kurepina N., Whitelaw A., Fallows D., Morrow C., Kreiswirth B., Kaplan G., Wood R. Molecular epidemiology of Mycobacterium tuberculosis in a South African community with high HIV prevalence. J. Infect. Dis. 2009, 200:1207-1211.
65. Moller M., de Wit E., Hoal E.G. Past, present and future directions in human genetic susceptibility to tuberculosis. FEMS Immunol. Med. Microbiol. 2010, 58:3-26.
66. Newton S.M., Smith R.J., Wilkinson K.A., Nicol M.P., Garton N.J., Staples K.J., Stewart G.R., Wain J.R., Martineau A.R., Fandrich S., Smallie T., Foxwell B., Al-Obaidi A., Shafi J., Rajakumar K., Kampmann B., Andrew P.W., Ziegler-Heitbrock L., Barer M.R., Wilkinson R.J. A deletion defining a common Asian lineage of Mycobacterium tuberculosis associates with immune subversion. Proc. Natl. Acad. Sci. USA 2006, 103:15594-15598.
67. Nicol M.P., Wilkinson R.J. The clinical consequences of strain diversity in Mycobacterium tuberculosis. Trans R Soc. Trop. Med. Hyg. 2008, 102:955-965.
68. Otsuka Y., Fujino T., Mori N., Sekiguchi J.-ichiro, Toyota E., Saruta K., Kikuchi Y., Sasaki Y., Ajisawa A., Otsuka Y., Nagai H., Takahara M., Saka H., Shirasaka T., Yamashita Y., Kiyosuke M., Koga H., Oka S., Kimura S., Mori T., Kuratsuji T., Kirikae T. Survey of human immunodeficiency virus (HIV)-seropositive patients with mycobacterial infection in Japan. J. Infect. 2005, 51:364-374.
69. Palmero D., Ritacco V., Ambroggi M., Marcela N., Barrera L., Capone L., Dambrosi A., di Lonardo M., Isola N., Poggi S., Vescovo M., Abbate E. Multidrug-resistant tuberculosis in HIV-negative patients, Buenos Aires, Argentina. Emerg. Infect. Dis. 2003, 9:965-969.
70. Parwati I., van Crevel R., van Soolingen D. Possible underlying mechanisms for successful emergence of the Mycobacterium tuberculosis Beijing genotype strains. Lancet Infect Dis. 2010, 10:103-111.
71. Portevin D., Gagneux S., Comas I., Young D. Human macrophage responses to clinical isolates from the mycobacterium tuberculosis complex discriminate between ancient and modern lineages. PLoS Pathog. 2011, 7:e1001307.
72. Reed M.B., Pichler V.K., McIntosh F., Mattia A., Fallow A., Masala S., Domenech P., Zwerling A., Thibert L., Menzies D., Schwartzman K., Behr M.A. Major Mycobacterium tuberculosis lineages associate with patient country of origin. J. Clin. Microbiol. 2009, 47:1119-1128.
73. Rieder H.L., Snider D.E., Cauthen G.M. Extrapulmonary tuberculosis in the United States. Am. Rev. Respir. Dis. 1990, 141:347-351.
74. Rodrigo T., Cayla J.A., Garcia de Olalla P., Galdos-Tanguis H., Jansa J.M., Miranda P., Brugal T. Characteristics of tuberculosis patients who generate secondary cases. Int. J. Tuberc. Lung Dis. 1997, 1:352-357.
75. Rouillon A., Perdrizet S., Parrot R. Transmission of tubercle bacilli: the effects of chemotherapy. Tubercle 1976, 57:275-299.
76. Sechi L.A., Zanetti S., Delogu G., Montinaro B., Sanna A., Fadda G. Molecular epidemiology of Mycobacterium tuberculosis strains isolated from different regions of Italy and Pakistan. J. Clin. Microbiol. 1996, 34(7):1825-1828.
77. Sergeev R., Colijn C., Cohen T. Models to understand the population-level impact of mixed strain M. tuberculosis infections. J. Theor. Biol. 2011, 280:88-100.
78. Shafer R.W., Kim D.S., Weiss J.P., Quale J.M. Extrapulmonary tuberculosis in patients with human immunodeficiency virus infection. Medicine (Baltimore) 1991, 70:384-397.
79. Shen J.Y., Barnes P.F., Rea T.H., Meyer P.R. Immunohistology of tuberculous adenitis in symptomatic HIV infection. Clin. Exp. Immunol. 1988, 72:186-189.
80. Telzak E.E., Fazal B.A., Turett G.S., Justman J.E., Blum S. Factors influencing time to sputum conversion among patients with smear-positive pulmonary tuberculosis. Clin. Infect. Dis. 1998, 26:775-776.
81. Thye T., Niemann S., Walter K., Homolka S., Intemann C.D., Chinbuah M.A., Enimil A., Gyapong J., Osei I., Owusu-Dabo E., Rusch-Gerdes S., Horstmann R.D., Ehlers S., Meyer C.G. Variant G57E of Mannose Binding Lectin associated with protection against tuberculosis caused by Mycobacterium africanum but not by M. tuberculosis. PLoS ONE 2011, 6:e20908.
82. Valway S.E., Sanchez M.P., Shinnick T.F., Orme I., Agerton T., Hoy D., Jones J.S., Westmoreland H., Onorato I.M. An outbreak involving extensive transmission of a virulent strain of Mycobacterium tuberculosis. N. Engl. J. Med. 1998, 338:633-639.
83. van Crevel R., Parwati I., Sahiratmadja E., Marzuki S., Ottenhoff T.H., Netea M.G., van der Ven A., Nelwan R.H., van der Meer J.W., Alisjahbana B., van de Vosse E. Infection with Mycobacterium tuberculosis Beijing genotype strains is associated with polymorphisms in SLC11A1/NRAMP1 in Indonesian patients with tuberculosis. J. Infect. Dis. 2009, 200:1671-1674.
84. van der Spuy G.D., Kremer K., Ndabambi S.L., Beyers N., Dunbar R., Marais B.J., van Helden P.D., Warren R.M. Changing Mycobacterium tuberculosis population highlights clade-specific pathogenic characteristics. Tuberculosis (Edinb) 2008, 89:120-125.
85. WHO Global tuberculosis control - surveillance, planning, financing 2010, WHO, Geneva, Switzerland.
86. Wirth T., Hildebrand F., Allix-Beguec C., Wolbeling F., Kubica T., Kremer K., van Soolingen D., Rusch-Gerdes S., Locht C., Brisse S., Meyer A., Supply P., Niemann S. Origin, spread and demography of the Mycobacterium tuberculosis complex. PLoS Pathog. 2008, 4:e1000160.
87. Woolhouse M.E., Webster J.P., Domingo E., Charlesworth B., Levin B.R. Biological and biomedical implications of the co-evolution of pathogens and their hosts. Nat. Genet. 2002, 32:569-577.
88. Yang Z.H., Mtoni I., Chonde M., Mwasekaga M., Fuursted K., Askgård D.S., Bennedsen J., de Haas P.E., van Soolingen D., van Embden J.D. DNA fingerprinting and phenotyping of Mycobacterium tuberculosis isolates from human immunodeficiency virus (HIV)-seropositive and HIV-seronegative patients in Tanzania. J. Clin. Microbiol. 1995, 33:1064-1069.
89. Zur Wiesch P.A., Kouyos R., Engelstadter J., Regoes R.R., Bonhoeffer S. Population biological principles of drug-resistance evolution in infectious diseases. Lancet Infect. Dis. 2011, 11:236-247.